Jump to content
April 2024 Challenge

John C. Staley

Members
 View Profile  See their activity

  • Posts

    1,552

  • Joined

  • Last visited

  • Days Won

    223

  • Country

    United States

 Content Type 

Everything posted by John C. Staley

  1. John C. Staley
    We have been forced to switch from Adsol RBCs to CPDA-1 for our neonates (long story and not important right now). Our SOP had been to give type O RBCs to any type A or type B neonate with a positive DAT due to maternal anti-A or anti-B. With ADSOL I wasn't concerned due to the removal of virtually 100% of the plasma. With CPDA-1 RBCs there is at least 20+% of the plasma still on the RBCs. I consider giving these babies type O as just adding more fuel to the fire. If we were to give them type specific RBCs the anti-A/anti-B would very quickly be removed but by providing type O we are just adding more anti-A/anti-B with every transfusion. The corporate clinical pathologist over transfusion services will not even consider anything but type O for these babies. What are others doing and can you see the logic in my argument or am I so far out in left field that it makes no sense to anyone but me? Thanks John
  2. John C. Staley
    We've required a minimum of 15 hours of CE for a number of years. Most of it is provided on site. We have enrolled in a couple of "on-line" activities as well as reading materials and check samples. There are local meetings that staff will occasionally attend but it has been a few years since we had any help for national meetings. I try to attend the Ann Arbor meeting every other year but asking for more than that is pushing the envelope.
  3. John C. Staley
    Let's give it a try. I think everything worked. I hope these help folks. There is no reason for everyone to have to re-invent the square wheel. MK4013-F1.doc Validation of Tube Transport of Blood blank form.doc MK4013v2- Issuing Blood via Tube.doc
  4. John C. Staley
    I tried but got the message "The Extension dot is not allowed". It is a word document. Any suggestions?
  5. John C. Staley
    I just e-mailed Jane a complete packet of info including SOPs and validation plans. I hope they help.
  6. John C. Staley
    Gigantic!!! Granted the Galileo is not counter top, but gigantic! :wink: Compared to some of the chemistry and hematology instruments, not to mention microbiology, it is almost pocket sized. You are right it is a little on the large size but I've already decided to take out the counter my ABS2000 sits on to accomodate it. Do you know the technology the Olympus Tango utilizes for ABO/Rh and Antibody Screens? I'm not that familiar with it. I've liked their microscopes but have not really been that impressed with their instruments. John
  7. John C. Staley
    Consider the cost of not having one. Would you need to hire more staff? Are mistakes happening that automation can prevent such as using outdatd reagents or forgetting to perform QC? Are you current staff being pushed to their limits and mistakes being made or "other duties as assigned" not being completed. I'm not sure of the price difference between the 2 but I can't imagine it is that much and I have found Immucor very willing to work with me. Also, consider the cost of operation, I do know that the cost of an ABO/Rh on the provue is considerably more that the cost on either the Galileo or the ABS2000.
  8. John C. Staley
    We have been using the ABS2000 since 1999. I am now in the process of getting the Galileo on the budget for purchase in 2006. I am not a fan of gel. Now you know my bias. With that said, I have looked at the PROVUE and was not impressed. While it is a step above the ABS2000 it has been surpassed by the Galileo in ease of use, cost per test, test volume and test menu. Actually I know of a facility in Colorado that did a side by side evaluation with the PROVUE and the ABS2000 and chose the ABS2000. To answer the next obvious question, no I'm not on Immucor's payroll I just don't mind sharing my opinion on something I feel strongly about. :wink:
  9. John C. Staley
    Our local reference lab really likes the phrase " xxx like antibody". Example, we told them it looked like an anti-e and three days later they reported "anti-e like antibody". Ya gotta love it. :roll:
  10. John C. Staley
    1. Albumin = Pharmacy 2. Clotting Factor concentrates = Pharmacy 3. Rh Immune Globulin-intramusular = Transfusion Service 4. Rh Immube Globulin-intravenous (WinRho) = ? Pharmacy (we don't) 5. IVIg = Pharmacy
  11. John C. Staley
    My first thought is too much microscope! :wink: What commercial anti-E are you using that requires reading with a microscope? Could the patient have been transfused at anyother facility between 9/12/03 and 12/5/03? One last question, was a control of the last wash run with the eluate and was it negative? (I'm assuming the answer is yes but I had to ask.)
  12. John C. Staley
    Well, it's been over a month. What happened :?: Don't leave us hanging. I didn't have anything to add that would have helped. We would have transfused the compatible units and sent sample off to the reference lab.
  13. John C. Staley
    Interface were one of the biggest items on our check list. Our interface gurus made sure all specifications were acceptable before any ink went on the contract. At this point in time the interfaces are the least of my concerns because of the investigation that occurred up front. 8)
  14. John C. Staley
    Currently we weak D type all patients that test negative on immediate spin with anti: D. :shock: I am trying to change that so we are only testing weak D on babies when doing RhIG workups on their mothers.
  15. John C. Staley
    While anti: E and anti: K are the 2 most common antibodies we find at my facility we do no preemptive antigen screening of units for women of child bearing age. They are treated no different than any other patients.
  16. John C. Staley
    On March 29th we start application and builder training for the Mediware HCLL system. We are installing it in 20+ hospitals ranging from 500+ beds to <20 beds. The expectation is everything will be standardized. A couple of the larger facilities will act as central testing centers for some of the smaller facilities. I think we will be testing the limits of the system not to mention our sanity. Burn a candle or 2 for us. :roll: :roll: :roll:
  17. John C. Staley
    LIS is Mysis. Transfusion Service is Life LIne/Western Star. We start application training and builder training to install the new Mediware product HCLL on March 29th. Wish us luck, we'll need it. The system will serve 20+ hospitals from 500 beds down to <20 beds within the corporation. Everything is expected to be standardized throughout. I fear my doom is near. :cry:
  18. John C. Staley
    I stopped using the scope for routine tube testing years ago (DATs are the exception). I have not see a dramatic increase in patient deaths because of it. The problem I have is, we use a manual PEG technique and the package insert recommends against microscopic reading. Many of my "more mature" techs can't seem to let go of the scope and they spend an awful lot of time chasing unicorns. :twisted:
  19. John C. Staley
    We are direct computer entry, no paper record. The expectation is that the computer entry be made immediately upon reading.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.